![]() |
Managing CML: Dealing With Drug Resistance
|
![]() |
Doctor and Patient Teamwork: Management of CML
|
![]() |
CML After Age 65: What are the Treatment Options?
|
![]() |
What problems with bone and joint pain do CML patients sometimes experence with Gleevec?
|
![]() |
What types of responses can people with CML have to therapy?
|
![]() |
When might doctors combine drugs in the treatment of CML?
|
![]() |
Facts to Know While Undergoing Therapy for CML
|
![]() |
What happens to blood cells when a person has CML?
|
![]() |
Side Effects of CML Therapy: What Can Be Done?
|
![]() |
What problems with fluid retention to CML patients sometimes have with Gleevec?
|
![]() |
What are the Phases of CML?
|
![]() |
What gastrointestinal problems do CML patients sometimes experience with Gleevec?
|
![]() |
Tracking Treatment Progress: Lab Tests For CML
|
![]() |
Learn to Read Your Lab Results: CML Tests
|
![]() |
The Faulty Gene Behind Chronic Myeloid Leukemia
|
![]() |
How have patient's experiences with CML changed in recent years?
|
|
|
But one of the great unknowns nowadays days is will prior Gleevec therapy effect the results of transplant subsequently? And that could happen in a number of ways.
ANNOUNCER: One concern is that delaying a transplant might increase risk. It's possible that the drug itself might lead to complications. And a patient who fails medical therapy, like Gleevec, might face a transplant with more advanced disease.
But it's also possible that using Gleevec may improve results in later transplants.
STEVE MACKINNON, MD: And the last thing to bear in mind is that Gleevec may put patients into remission prior to transplantation. And that has a possibility of actually improving the results of transplantation.
ANNOUNCER: No doctor is ready to call Gleevec a cure for CML. But if research shows Gleevec prolongs survival, doctors say many CML patients may enjoy long, symptom-free lives, without the trauma and risk of a bone marrow transplant.